224 related articles for article (PubMed ID: 29531380)
1. [Nutraceuticals: a useful tool for cardiologists to improve lipid profile?].
Covolo E; Bilato C
G Ital Cardiol (Rome); 2018 Feb; 19(2):81-90. PubMed ID: 29531380
[TBL] [Abstract][Full Text] [Related]
2. Nutraceuticals and functional foods in the management of hyperlipidemia.
Chen G; Wang H; Zhang X; Yang ST
Crit Rev Food Sci Nutr; 2014; 54(9):1180-201. PubMed ID: 24499150
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of Nutraceuticals with Lipid Lowering Properties.
Poli A; Visioli F
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):113-118. PubMed ID: 30877602
[TBL] [Abstract][Full Text] [Related]
4. Lipid-lowering nutraceuticals update on scientific evidence.
Derosa G; Colletti A; Maffioli P; D'Angelo A; Lupi A; Zito GB; Mureddu GF; Raddino R; Fedele F; Cicero AFG
J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):845-859. PubMed ID: 32639326
[TBL] [Abstract][Full Text] [Related]
5. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
Duntas L; Kolovou G
Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
[No Abstract] [Full Text] [Related]
6. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients.
Pascual Fuster V
Rev Esp Sanid Penit; 2016 Dec; 18(3):95-108. PubMed ID: 27831597
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for hyperlipidemia.
Paras C; Hussain MM; Rosenson RS
Expert Opin Emerg Drugs; 2010 Sep; 15(3):433-51. PubMed ID: 20423271
[TBL] [Abstract][Full Text] [Related]
9. Management of Statin Intolerance in 2018: Still More Questions Than Answers.
Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M
Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532
[TBL] [Abstract][Full Text] [Related]
10. Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management.
Johnston TP; Korolenko TA; Pirro M; Sahebkar A
Pharmacol Res; 2017 Jun; 120():219-225. PubMed ID: 28408313
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.
Cicero AF; Ferroni A; Ertek S
Expert Opin Drug Saf; 2012 Sep; 11(5):753-66. PubMed ID: 22788832
[TBL] [Abstract][Full Text] [Related]
12. The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease.
Rivellese AA; Ciciola P; Costabile G; Vetrani C; Vitale M
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):101-111. PubMed ID: 30811011
[TBL] [Abstract][Full Text] [Related]
13. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Cicero AFG; Fogacci F; Stoian AP; Vrablik M; Al Rasadi K; Banach M; Toth PP; Rizzo M
Curr Atheroscler Rep; 2021 Aug; 23(10):57. PubMed ID: 34345932
[TBL] [Abstract][Full Text] [Related]
14. Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?
Kostapanos MS; Katsiki N; Elisaf MS; Mikhailidis DP
Curr Vasc Pharmacol; 2012 Mar; 10(2):173-7. PubMed ID: 22250844
[No Abstract] [Full Text] [Related]
15. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
Margaritis M; Antoniades C
Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
[No Abstract] [Full Text] [Related]
16. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.
Micallef MA; Garg ML
J Nutr Biochem; 2009 Dec; 20(12):927-39. PubMed ID: 19733044
[TBL] [Abstract][Full Text] [Related]
17. Severely frail elderly patients do not need lipid-lowering drugs.
Mallery LH; Moorhouse P; McLean Veysey P; Allen M; Fleming I
Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686
[TBL] [Abstract][Full Text] [Related]
18. Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.
Becker DJ; French B; Morris PB; Silvent E; Gordon RY
Am Heart J; 2013 Jul; 166(1):187-96. PubMed ID: 23816039
[TBL] [Abstract][Full Text] [Related]
19. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for hyperlipidaemia: an update.
Florentin M; Kostapanos MS; Kei A; Elisaf MS
Expert Opin Emerg Drugs; 2014 Dec; 19(4):471-88. PubMed ID: 25356785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
